Na Formiventos damos as boas-vindas à Drª Margarida Guimarães como nova integrante do ADVISORY BOARD, sendo este comité assessor composto por uma seleção de profissionais experientes nas suas respetivas áreas de conhecimento, com a missão de identificar, propor e decidir os tópicos mais pertinentes e os conteúdos mais relevantes estando habilitados a partilhar toda a sua experiência real com os nossos Clientes.
News & Trends
Procurar
Recentes
- Commission publishes guidelines on transparency obligations for providers and deployers of certain AI systems
- MDCG Position Paper: UDI assignment between manufacturers and distributors
- EMA Questions & answers on Article 31 non-pharmacovigilance referral procedures
- EXTENSION OF THE MDR TRANSITIONAL PERIOD AND REMOVAL OF THE ‘SELL OFF’ PERIODS
- MHRA Updated guidance for the International Recognition Procedure (IRP)
- MDCG 2021-5 Rev. 1 .Guidance on standardisation for medical devices
- Qualification of novel methodologies (QoNM) for medicinal product development . Procedural Guidance to applicants
- FDA Guidance for Drug Development